Business Wire

project44 Launches First Supply Chain Industry Preferred Telematics Program


project44, the leader in real-time supply chain visibility, unveiled its new Preferred Telematics Program, accessible to carriers through the project44 website. The industry-first Preferred Telematics Program reduces the cost of purchasing and installing telematics devices on vehicles by delivering discounted fleet management solutions and dedicated sales channels for project44 carriers through the program’s partners. In addition, carriers can take advantage of industry-leading fleet management, driver performance, and workflow automation solutions. The program’s inaugural partners include Astrata, Ruptela, SafeFleet, Webfleet Solutions, and ZF (through its Transics FMS).

According to industry research and project44’s ongoing value engineering initiatives with customers, lack of visibility is costing the industry up to €50/$68 per load in operational effort and administration in the form of inefficiencies – such as the ability to plan and manage exceptions – and is hindering digitalization efforts. Carriers can use these technologies to navigate supply chain disruptions and save upwards of 10% of their operating costs through more efficient utilization of fleets.

“project44 continues to lay the groundwork for the most data-intensive global transportation ecosystem yet,” said Jett McCandless, CEO and founder of project44. “The Preferred Telematics Program opens a new path to digitalize the trucking industry, transforming it into a truly efficient space with visibility software at the core of global road freight tracking.”

Carriers in project44’s network can take advantage of exclusive solutions and discounts offered only by program partners. One such technology solution, project44 One-Click OnboardingTM, accelerates integrations between leading telematics systems and project44’s global supply chain visibility platform via native integration, allowing carriers to get connected in a single click instead of relying on manually generated API keys to establish connections. The innovation cuts carrier integration times from weeks to seconds and expedites time to value for project44 customers.

According to the European Fleet Management Market Report, the installation base of fleet management systems in the European Union is expected to grow at a compound annual growth rate of 14.1 percent, reaching 17.6 million units by 2023, with the penetration rate in non-privately owned commercial vehicles and cars estimated to increase from 17.4 percent in 2018 to 32 percent in 2023.

“Through the Preferred Telematics Program, project44 can get carriers connected and send their customers high-quality data by giving small- and medium-sized fleets access to similar solutions and pricing as large fleets,” said Anjuli Steffen, vice president of global networks at project44. “Telematics vendors are an essential part of the project44 ecosystem, and we are excited to deepen our collaboration with these strategic partners to simplify the data sharing experience for carriers and instantly meet the visibility requirements of leading LSP and shipper customers.”

Trusted Partners

Collectively, the Preferred Telematics Program’s inaugural members provide products and services to more than 15,000 carriers operating over 825,000 assets throughout Europe. All partners in the program have been integrated with project44 for at least 12 months, and were selected based on their existing market reach, newly dedicated onboarding resources, and willingness to build technological or commercial solutions for project44’s network. Additional partners will be considered for the program in 2022.

Taco van der Leij, vice president of Webfleet Solutions Europe said, “We are excited to partner with project44 to offer our transport customers additional value in shipment visibility. The one-click concept provides easy, quick, and secure access for data sharing and management. When using WEBFLEET for data exchange, carriers have complete control over what information they share, when, and how.”

Peter Bal, Business Leader Digital Customer Services EMEA, ZF Commercial Vehicle Control Systems said, “Operators are increasingly turning to digital solutions to enable them to remain competitive in the market as road haulage becomes ever more complex, driven by new regulations, rising cost pressures and an expectation that fleets can deliver ever more quickly, safely, sustainably and reliably. Through our partnership with project44, ZF is enabling transparency across entire logistics flows. This contributes significantly to making the logistics industry leaner, safer and greener in their daily operational activities.”

Claudiu Suma, CEO of SafeFleet said, “In the extremely competitive field of telematics, there is no workaround to excellence other than quality service, a customer-centric approach and a continuous strive for improvement. This has been our guiding principle for over two decades. We are beyond excited to share this vision with project44 and strongly believe that together we can provide unmatched value to the carrier community.”

Andrius Rupšys, founder and CEO of Ruptela said, “We are honored to be amongst the first members of project44’s Preferred Telematics Program and share project44’s vision for enabling carriers of all sizes with the technology to provide shippers and LSPs with the real-time visibility they need. With Ruptela‘s affordable solution and local presence, we ensure carriers get quick and easy onboarding.”

Martijn Koch, Global OEM sales at Astrata said, “We are proud to partner with project44 and enrich their Advanced Visibility Platform with Astrata’s strong foundations and knowledge in geolocation, telematics and fleet management systems. We are also beyond excited to add value to project44’s vision in supply chain visibility with our mobile workflow management application Mission Planner and provide real-time driver feedback for all stakeholders.”

Click here or to learn more about project44’s Preferred Telematics Program or to apply to become a preferred provider.

About project44

project44 is the world’s leading advanced visibility platform for shippers and logistics service providers. project44 connects, automates and provides visibility into key transportation processes to accelerate insights and shorten the time it takes to turn those insights into actions. Leveraging the power of the project44 cloud-based platform, organizations increase operational efficiencies, reduce costs, improve shipping performance, and deliver an exceptional Amazon-like experience to their customers. Connected to thousands of carriers worldwide and having comprehensive coverage for all ELD and telematics devices on the market, project44 supports all transportation modes and shipping types, including Air, Parcel, Final-Mile, Less-than-Truckload, Volume Less-than-Truckload, Groupage, Truckload, Rail, Intermodal, and Ocean. In 2021, project44 was named a Leader among Real-Time Transportation Visibility Providers in Gartner’s Magic Quadrant. To learn more, visit

To view this piece of content from, please give your consent at the top of this page.

Contact information

Media Contact
Rebecca Selby
SVP, Corporate Marketing

About Business Wire

Business Wire
Business Wire

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)18.9.2021 15:34:00 CEST | Press release

Celltrion Group announced that the Korean Ministry of Food and Drug Safety (MFDS) approved regdanvimab (CT-P59), a monoclonal antibody treatment for COVID-19 for the extended use in elderly patients aged 50 years and over, or with at least one underlying medical condition (the obese, cardiovascular disease, chronic lung disease, diabetes, chronic kidney disease, chronic liver disease, and patients with immunosuppressive agents) with mild symptoms of COVID-19, and adult patients with moderate symptoms of COVID-19. This marks the first time a monoclonal antibody treatment for COVID-19 has received a full approval to treat patients with COVID-19 from the Korean MFDS. In February, the Korean MFDS granted a Conditional Marketing Authorisation (CMA) for the emergency use of regdanvimab (CT-P59) and allowed the use of CT-P59 in adult patients aged 60 years and over, or with at least one underlying medical condition (cardiovascular, chronic respiratory disease, diabetes, high blood pressure) w

Ipsen: ESMO 2021: Cabometyx ® Demonstrates Sustained 78% Reduction in Risk of Disease Progression or Death in People Living With Uncommon Form of Thyroid Cancer18.9.2021 06:30:00 CEST | Press release

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced presentation of new analyses at the European Society for Medical Oncology (ESMO) Congress 2021 across different forms of cancer for people treated with Cabometyx® (cabozantinib). Of note, the final analysis of the pivotal Phase III COSMIC-311 trial (Abstract LBA67) will be presented, with Cabometyx demonstrating a clinically meaningful, sustained efficacy benefit versus placebo in people living with previously treated radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC). With a median follow-up of 10.1 months, Cabometyx continued to demonstrate superior median progression-free survival (mPFS) with a reduction in the risk of disease progression or death of 78% versus placebo (hazard ratio [HR]: 0.22, 96% confidence interval [CI]: 0.15-0.32; p<0.0001).1 This final analysis is consistent with data from the interim analysis, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2021

Unifrax Hosts Groundbreaking Ceremony for SiFAB™ Manufacturing Line17.9.2021 20:46:00 CEST | Press release

Today, Unifrax, a leading manufacturer of high-performance specialty materials, held a ceremonial event celebrating its first large-scale SiFAB™ Silicon Fiber Anode Battery Technology manufacturing line, which is currently under construction at the company’s north central Indiana facility. This press release features multimedia. View the full release here: Unifrax team celebrates SiFAB groundbreaking at New Carlisle plant. (Photo: Business Wire) The event recognized Unifrax’s ongoing partnership with the State of Indiana and St. Joseph County, along with SiFAB’s continued progress. Unifrax executives, along with the SiFAB manufacturing team and local and state government officials, kicked off the ceremony at 10 a.m. EDT at the New Carlisle, IN plant, with remarks by John Dandolph, president and CEO, Unifrax. “Through the support of the State of Indiana and St. Joseph County, we have the ability to leverage our existing New Carli

Prince William announces 15 Finalists for inaugural year of the £50 million Earthshot Prize17.9.2021 19:01:00 CEST | Press release

The Earthshot Prize announces today its first-ever shortlist of 15 Finalists, each with a chance of winning £1million to support their innovative environmental solutions to the greatest challenges facing the planet. Prince William said: "Over half a century ago, President Kennedy’s ‘Moonshot’ programme united millions of people around the goal of reaching the moon. Inspired by this, The Earthshot Prize aims to mobilise collective action around our unique ability to innovate, problem solve and repair our planet. “I am honoured to introduce the 15 innovators, leaders, and visionaries who are the first ever Finalists for The Earthshot Prize. They are working with the urgency required in this decisive decade for life on Earth and will inspire all of us with their optimism in our ability to rise to the greatest challenges in human history.” Launched by Prince William and The Royal Foundation in October 2020, The Earthshot Prize is the most prestigious global environment prize in history. Li

Wipro Announces Co-innovation Space with Google Cloud17.9.2021 15:32:00 CEST | Press release

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today announced the launch of the Wipro-Google Cloud Innovation Arena in Bangalore, India. This cloud collaboration space will provide in-house technical expertise, ensure seamless cloud adoption, and accelerate innovation to drive business transformation for customers. By combining the expertise and resources of Wipro FullStride Cloud Services and Google Cloud, this jointly developed innovation center will offer a unique combination of people, processes, and platforms that will collectively create a futuristic experience for customers globally. This state-of-the-art arena will showcase the talent, tools and best practices required to develop and deploy applications on Google Cloud. Jason Eichenholz, Senior Vice President, Global Head of Ecosystems & Partnerships, Wipro Limited said, “We are excited to strengthen our partnership with Google Clou

Zynga Announces ReVamp, the First Multiplayer Social Deception Game For Snapchat17.9.2021 15:00:00 CEST | Press release

Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, announced today that ReVamp, an upcoming multiplayer social deception game, will launch soon in select markets exclusively for Snapchat. The vampire-themed game will be the first social deception title on Snapchat, giving Snapchatters their first chance to sink their teeth into this popular genre. This press release features multimedia. View the full release here: Zynga Announces ReVamp, the First Multiplayer Social Deception Game For Snapchat (Graphic: Business Wire) ReVamp is a real-time multiplayer imposter game where players aim to reveal who the vampire player is among their group of friends while they renovate the rooms of an old mansion. In the game, human players must complete renovation tasks, such as demolition and building, to improve their chances of survival while identifying and defeating the vampire during the voting phase. Vampire players mu

BeiGene Receives Positive CHMP Opinion for BRUKINSA ® (Zanubrutinib) for the Treatment of Adults with Waldenström’s Macroglobulinemia17.9.2021 14:00:00 CEST | Press release

BeiGene (NASDAQ: BGNE; HKEX: 06160) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending approval of BRUKINSA (zanubrutinib) for the treatment of adult patients with Waldenström’s macroglobulinemia (WM) who have received at least one prior therapy or first-line treatment for patients unsuitable for chemo-immunotherapy. “Bruton’s tyrosine kinase (BTK) inhibitors have emerged as a promising treatment for WM, yet treatment discontinuation due to lack of response or side effects remains a concern,” said Prof. Christian Buske, Medical Director at the University Hospital Ulm, Germany, and a trial investigator of the ASPEN study. “The ASPEN trial demonstrated that BRUKINSA provided deep and durable responses and offered substantial improvements in safety and tolerability over standard therapy. Patients in Europe with WM may soon have a new treatment option that can offer improved outcomes.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom